Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
A Phase II, Open-label, Randomized Controlled Study of PDR001 in Patients With Moderately Differentiated/Undifferentiated Locally Advanced Recurrent or Metastatic Nasopharyngeal Carcinoma Who Progressed on Standard Treatment
Sponsor: Novartis Pharmaceuticals
Listed as NCT02605967, this PHASE2 trial focuses on Nasopharyngeal Carcinoma and remains completed. Sponsored by Novartis Pharmaceuticals, it has been updated 30 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
30 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE2
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE2
▶ Show 25 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Completed PHASE2
-
Sep 2021 — Dec 2021 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Mar 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
May 2020 — Jul 2020 [monthly]
Recruiting PHASE2
-
Mar 2020 — May 2020 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE2
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE2
-
Aug 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Mar 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Sep 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Apr 2017 — Jul 2017 [monthly]
Recruiting PHASE2
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .